Venter Pharma has developed LacTEST®, a diagnostic drug for the diagnosis of lactose intolerance that overcomes the deficiencies of current methods. LacTEST® is based on a new molecule: gaxilose

Venter Pharma is a biotech Company created in 2003 with the aim of developing products in the field of gastroenterology to help patients and professionals. (Venter means "digestive tract" in latin.)

The company´s first product finished the development process in 2009 and the European authorization process in 2011. Now the company is waiting for the approval of the Spanish and German health Agencies.

LacTEST® will help professionals to manage the lactose intolerance disease in a more efficient way. Sufferers of lactose deficiency have a reduced capacity to digest lactose and experience various symptoms after lactose intake such as abdominal bloating, diarrhea, abdominal cramp, flatulence, nausea, etc. depending on the degree of intolerance of each individual.

Lactose intolerance is one of the most common genetic disorders affecting nearly half of the world population and is mostly under diagnosed as a consequence of the deficiencies of currents diagnostics methods, that means not properly managed according to NIH Consensus Development Conference: Lactose Intolerance and Health